CAREDX, INC. (CDNA) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | Gross Profit |
| Revenue | 458.09M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | (m) | $458.09M | (m) | (m) |
| 2026-03-31 | (m) | $412.82M | (m) | (m) |
| 2025-12-31 | (m) | $379.81M | (m) | (m) |
| 2025-09-30 | (m) | $358.00M | (m) | (m) |
| 2025-06-30 | (m) | $340.83M | (m) | (m) |
| 2025-03-31 | (m) | $346.42M | (m) | (m) |
| 2024-12-31 | (m) | $333.79M | (m) | (m) |
| 2024-09-30 | (m) | $312.77M | (m) | (m) |
| 2024-06-30 | (m) | $297.08M | (m) | (m) |
| 2024-03-31 | (m) | $275.11M | (m) | (m) |
| 2023-12-31 | (m) | $280.32M | (m) | (m) |
| 2023-09-30 | (m) | $297.14M | (m) | (m) |
| 2023-06-30 | (m) | $309.31M | (m) | (m) |
| 2023-03-31 | (m) | $319.64M | (m) | (m) |
| 2022-12-31 | (m) | $321.79M | (m) | (m) |
| 2022-09-30 | (m) | $318.63M | (m) | (m) |
| 2022-06-30 | (m) | $314.86M | (m) | (m) |
| 2022-03-31 | (m) | $308.41M | (m) | (m) |
| 2021-12-31 | (m) | $296.40M | (m) | (m) |
| 2021-09-30 | (m) | $275.82M | (m) | (m) |
| 2021-06-30 | (m) | $253.60M | (m) | (m) |
| 2021-03-31 | (m) | $221.21M | (m) | (m) |
| 2020-12-31 | (m) | $192.19M | (m) | (m) |
| 2020-09-30 | (m) | $169.37M | (m) | (m) |
| 2020-06-30 | $98.19M | $149.81M | (m) | 65.54% |
| 2020-03-31 | $91.35M | $139.47M | (m) | 65.50% |
| 2019-12-31 | $81.61M | $127.07M | (m) | 64.23% |
| 2019-09-30 | (m) | $114.76M | (m) | (m) |
| 2019-06-30 | (m) | $102.13M | (m) | (m) |
| 2019-03-31 | (m) | $88.50M | (m) | (m) |
| 2018-12-31 | (m) | $76.57M | (m) | (m) |
| 2018-09-30 | (m) | $65.56M | (m) | (m) |
| 2018-06-30 | (m) | $56.57M | (m) | (m) |
| 2018-03-31 | (m) | $50.79M | (m) | (m) |
| 2017-12-31 | (m) | $48.32M | (m) | (m) |
| 2017-09-30 | (m) | $46.68M | (m) | (m) |
| 2017-06-30 | (m) | $46.96M | (m) | (m) |
| 2017-03-31 | (m) | $45.65M | (m) | (m) |
| 2016-12-31 | (m) | $40.63M | (m) | (m) |
| 2016-09-30 | (m) | $36.42M | (m) | (m) |
| 2016-06-30 | (m) | $31.10M | (m) | (m) |
| 2016-03-31 | (m) | $27.49M | (m) | (m) |
| 2015-12-31 | (m) | $28.14M | (m) | (m) |
| 2015-09-30 | (m) | $29.45M | (m) | (m) |
| 2015-06-30 | (m) | $28.95M | (m) | (m) |
| 2015-03-31 | (m) | $28.60M | (m) | (m) |
| 2014-12-31 | (m) | $27.31M | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | $23.04M | (m) | (m) |
| 2013-12-31 | (m) | $22.10M | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $20.45M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |